We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Nanoparticle Suspension Captures and Purifies DNA from High-Value Samples

By Labmedica staff writers
Posted on 03 Apr 2008
A kit containing a coated nanoparticle suspension is optimized to capture and purify DNA from small, high-value samples, especially clinical or forensic isolates.

The nanoXtract kit with PrepParticles is very simple to use. More...
The PrepParticle suspension is pipetted directly into a crude sample, mixed with a binding buffer and centrifuged. Purified DNA is then released into that same tube, in a concentrated form, ready for genetic analysis. Easy-to-use protocols (manual and automated) are available for DNA isolation from blood, thin sections, and swabs.

A product of Argylla Technologies LLC (Tucson, AZ, USA), the nanoXtract kit with PrepParticles belongs to a suite of simple-to-use products being developed for the manipulation, capture, purification, and concentration of DNA, RNA, and proteins. The high-density nanoparticles form extremely stable suspensions with enormous surface areas in biologic fluids. Argylla exploited the unique physical properties of nanoparticles in suspension, and coated these particles with biomolecule-specific films to create a new class of tools for the biotechnology marketplace.

The extraction-capture-concentration process scales from liter size samples to samples as small as a 1/100th of a milliliter by a simple adjustment of the proportion of the Argylla particles used in the preparation. The PrepParticle can process samples yielding as little as 100 picograms of DNA.

The Argylla kit products can process micro-dissected clinical biopsies, crime scene wipes, clinical skin swabs, and clinical samples such as bacterial swabs. They are extremely simple to use, cost effective, and possess rapid binding kinetics associated with NanoChromatography processes. The nanoparticle matrix has enormous binding capacity, and the whole extraction process, from start to finish, is performed within one low cost standard microfuge tube.


Related Links:
Argylla Technologies

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.